Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hart

Showing results (831-840 of 909) with videos related to

Pageof 91
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2016
Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver CancerRafael Duran, Sahar Mirpour, Vasily Pekurovsky, et al.
British Journal of Clinical Pharmacology|April 23, 2021
Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M<sub>1</sub> -acetylcholine receptor agonist: A randomized cross-over trialCharlotte Bakker, Samantha Prins, Jan Liptrot, et al.
Oncogene|April 4, 2017
Selected mitochondrial DNA landscapes activate the SIRT3 axis of the UPR<sup>mt</sup> to promote metastasisT C Kenny, P Hart, M Ragazzi, et al.
The Annals of Thoracic Surgery|January 17, 2004
Echocardiographic analysis of ventricular geometry and function during repair of congenital septal defectsJoseph P Hart, Santos E Cabreriza, Rowan F Walsh, et al.
Plos One|September 26, 2014
Pyruvate induces transient tumor hypoxia by enhancing mitochondrial oxygen consumption and potentiates the anti-tumor effect of a hypoxia-activated prodrug TH-302Yoichi Takakusagi, Shingo Matsumoto, Keita Saito, et al.
The Lancet. Gastroenterology & Hepatology|May 18, 2020
Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation studyGuolan Lu, Nynke S van den Berg, Brock A Martin, et al.
Journal of Medicinal Chemistry|February 9, 2008
Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugsJian-Xin Duan, Hailong Jiao, Jacob Kaizerman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2015
TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET ImagingSarah G J A Peeters, Catharina M L Zegers, Rianne Biemans, et al.
AJNR. American Journal of Neuroradiology|August 25, 2012
Magnetization transfer imaging in premanifest and manifest huntington disease: a 2-year follow-upS J A van den Bogaard, E M Dumas, E P Hart, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 9, 2019
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studiesPeter Volkers, Kay-Martin Hanschmann, Thierry Calvez, et al.
Pageof 91

Showing results (831-840 of 909) with videos related to

Sort By:
Pageof 91
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2016
Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver CancerRafael Duran, Sahar Mirpour, Vasily Pekurovsky, et al.
British Journal of Clinical Pharmacology|April 23, 2021
Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M<sub>1</sub> -acetylcholine receptor agonist: A randomized cross-over trialCharlotte Bakker, Samantha Prins, Jan Liptrot, et al.
Oncogene|April 4, 2017
Selected mitochondrial DNA landscapes activate the SIRT3 axis of the UPR<sup>mt</sup> to promote metastasisT C Kenny, P Hart, M Ragazzi, et al.
The Annals of Thoracic Surgery|January 17, 2004
Echocardiographic analysis of ventricular geometry and function during repair of congenital septal defectsJoseph P Hart, Santos E Cabreriza, Rowan F Walsh, et al.
Plos One|September 26, 2014
Pyruvate induces transient tumor hypoxia by enhancing mitochondrial oxygen consumption and potentiates the anti-tumor effect of a hypoxia-activated prodrug TH-302Yoichi Takakusagi, Shingo Matsumoto, Keita Saito, et al.
The Lancet. Gastroenterology & Hepatology|May 18, 2020
Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation studyGuolan Lu, Nynke S van den Berg, Brock A Martin, et al.
Journal of Medicinal Chemistry|February 9, 2008
Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugsJian-Xin Duan, Hailong Jiao, Jacob Kaizerman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2015
TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET ImagingSarah G J A Peeters, Catharina M L Zegers, Rianne Biemans, et al.
AJNR. American Journal of Neuroradiology|August 25, 2012
Magnetization transfer imaging in premanifest and manifest huntington disease: a 2-year follow-upS J A van den Bogaard, E M Dumas, E P Hart, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 9, 2019
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studiesPeter Volkers, Kay-Martin Hanschmann, Thierry Calvez, et al.
Pageof 91